32664-14-5

4,4-Dimethyl-2-(4-bromophenyl)-2-oxazoline is an potential substituent in the synthesis of new series of potent benzodiazepine γ-secretase inhibitors with potential use in the treatment of Alzheimer’s disease.

Synthetic Communications, 26, p. 1335, 1996 DOI: 10.1080/00397919608003493